The treatment-induced PPARG down-regulation and LDLR up-regulation in addition to adverse inductions of TNF and COL1A1 after four weeks NPC2 treatment may explain the overall lack of improvement in NASH changes. Here, COL1A1 is linked to metabolic dysfunction-associated steatohepatitis.